Retrospective analysis of microbiome in idiopathic pulmonary fibrosis.

Y. Takahashi (Sapporo, Japan)

Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways

Session: Interstitial lung diseases (ILDs): novel pathogenetic pathways
Session type: Oral Presentation
Number: 476

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Takahashi (Sapporo, Japan). Retrospective analysis of microbiome in idiopathic pulmonary fibrosis.. 476

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study. Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers Year: 2018
Retrospective studies of the association between idiopathic pulmonary fibrosis and lifestyle-related disease Source: Eur Respir J 2007; 30: Suppl. 51, 577s Year: 2007
Retrospective analysis of acute exacerbation in idiopathic interstitial pneumonias Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009
Combined pulmonary fibrosis and emphysema. Descriptive analysis from a specialized clinic of interstitial lung disease Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011
Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010
Retrospective study on the treatment and prognosis of acute exacerbation of idiopathic pulmonary fibrosis in Japan Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010
Retrospective analysis of CT before and after azithromycin therapy in non-cystic fibrosis bronchiectasis using a modified Brody-score Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010
Cluster analysis and survival in patients with Idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016
Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort Source: ERJ Open Res, 5 (1) 00014-2018; 10.1183/23120541.00014-2018 Year: 2019
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008
Final analysis of RECAP, an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment I Year: 2016
Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis Source: ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020 Year: 2020
Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020
Pirfenidone treatment for idiopathic pulmonary fibrosis (IPF): a comprehensive analysis of safety Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009
Patterns of pulmonary hypertension in Egyptian patients with COPD: A retrospective analysis Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021
Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017 Year: 2017
Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017
Immunogenetic background of children´s idiopathic interstitial pneumonias and adult idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016